Global Nsaids Market Research Report 2023
Global Nsaids Market Overview:
Global Nsaids Market Report 2022 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2022-2028.This research study of Nsaids involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Nsaids Market
The Nsaids Market Research report incorporate value chain analysis for each of the product type. Value chain analysis offers in depth information about value addition at each stage.The study includes drivers and restraints for Nsaids Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Nsaids Market helps user to make precise decision in order to expand their market presence and increase market share.
Impact of COVID-19 on Nsaids Market
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Nsaids market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
Global Nsaids Market Segmentation
Global Nsaids Market Research report comprises of Porter's five forces analysis to do the detail study about its each segmentation like Product segmentation, End user/application segment analysis and Major key players analysis mentioned as below;
By Type, Nsaids market has been segmented into:
Aspirin
Ibuprofen
Naproxen
Nabumetone
Others
By Application, Nsaids market has been segmented into:
Back Pain Treatment
Osteoarthritis Treatment
Other Disease Treatment
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Nsaids market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Nsaids market.
Top Key Players Covered in Nsaids market are:
Shandong Xinhua Pharmaceutical Co Ltd
Zhejiang Jiuzhou Pharmaceutical
Pfizer
Boehringer Ingelheim
Hisoar
Strides Shasun
Amgen
Johnson and Johnson
IOLCP
Sanofi
Merck
GSK
Roche (Genentech)
SI Group
Granules Biocause
Zibo Xinhua-Perrigo Pharmaceutical Co.
Ltd.
BASF
Novartis
Eli Lilly and Company
Objective to buy this Report:
1. Nsaids analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Nsaids market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Global Nsaids Market Report 2022 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2022-2028.This research study of Nsaids involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Nsaids Market
The Nsaids Market Research report incorporate value chain analysis for each of the product type. Value chain analysis offers in depth information about value addition at each stage.The study includes drivers and restraints for Nsaids Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Nsaids Market helps user to make precise decision in order to expand their market presence and increase market share.
Impact of COVID-19 on Nsaids Market
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Nsaids market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
Global Nsaids Market Segmentation
Global Nsaids Market Research report comprises of Porter's five forces analysis to do the detail study about its each segmentation like Product segmentation, End user/application segment analysis and Major key players analysis mentioned as below;
By Type, Nsaids market has been segmented into:
Aspirin
Ibuprofen
Naproxen
Nabumetone
Others
By Application, Nsaids market has been segmented into:
Back Pain Treatment
Osteoarthritis Treatment
Other Disease Treatment
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Nsaids market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Nsaids market.
Top Key Players Covered in Nsaids market are:
Shandong Xinhua Pharmaceutical Co Ltd
Zhejiang Jiuzhou Pharmaceutical
Pfizer
Boehringer Ingelheim
Hisoar
Strides Shasun
Amgen
Johnson and Johnson
IOLCP
Sanofi
Merck
GSK
Roche (Genentech)
SI Group
Granules Biocause
Zibo Xinhua-Perrigo Pharmaceutical Co.
Ltd.
BASF
Novartis
Eli Lilly and Company
Objective to buy this Report:
1. Nsaids analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Nsaids market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
CHAPTER 1: INTRODUCTION
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
CHAPTER 2:EXECUTIVE SUMMARY
CHAPTER 3:GROWTH OPPORTUNITIES BY SEGMENT
3.1 By Type
3.2 By Application
CHAPTER 4: MARKET LANDSCAPE
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
CHAPTER 5: NSAIDS MARKET BY TYPE
5.1 Nsaids Market Overview Snapshot and Growth Engine
5.2 Nsaids Market Overview
5.3 Aspirin
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2016-2028F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Aspirin: Geographic Segmentation
5.4 Ibuprofen
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2016-2028F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Ibuprofen: Geographic Segmentation
5.5 Naproxen
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2016-2028F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Naproxen: Geographic Segmentation
5.6 Nabumetone
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2016-2028F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Nabumetone: Geographic Segmentation
5.7 Others
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size (2016-2028F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Others: Geographic Segmentation
CHAPTER 6: NSAIDS MARKET BY APPLICATION
6.1 Nsaids Market Overview Snapshot and Growth Engine
6.2 Nsaids Market Overview
6.3 Back Pain Treatment
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2016-2028F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Back Pain Treatment: Geographic Segmentation
6.4 Osteoarthritis Treatment
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2016-2028F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Osteoarthritis Treatment: Geographic Segmentation
6.5 Other Disease Treatment
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2016-2028F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Other Disease Treatment: Geographic Segmentation
CHAPTER 7: COMPANY PROFILES AND COMPETITIVE ANALYSIS
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Nsaids Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Nsaids Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Nsaids Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 SHANDONG XINHUA PHARMACEUTICAL CO LTD
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 ZHEJIANG JIUZHOU PHARMACEUTICAL
7.4 PFIZER
7.5 BOEHRINGER INGELHEIM
7.6 HISOAR
7.7 STRIDES SHASUN
7.8 AMGEN
7.9 JOHNSON AND JOHNSON
7.10 IOLCP
7.11 SANOFI
7.12 MERCK
7.13 GSK
7.14 ROCHE (GENENTECH)
7.15 SI GROUP
7.16 GRANULES BIOCAUSE
7.17 ZIBO XINHUA-PERRIGO PHARMACEUTICAL CO.
7.18 LTD.
7.19 BASF
7.20 NOVARTIS
7.21 ELI LILLY AND COMPANY
CHAPTER 8: GLOBAL NSAIDS MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Aspirin
8.2.2 Ibuprofen
8.2.3 Naproxen
8.2.4 Nabumetone
8.2.5 Others
8.3 Historic and Forecasted Market Size By Application
8.3.1 Back Pain Treatment
8.3.2 Osteoarthritis Treatment
8.3.3 Other Disease Treatment
CHAPTER 9: NORTH AMERICA NSAIDS MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Aspirin
9.4.2 Ibuprofen
9.4.3 Naproxen
9.4.4 Nabumetone
9.4.5 Others
9.5 Historic and Forecasted Market Size By Application
9.5.1 Back Pain Treatment
9.5.2 Osteoarthritis Treatment
9.5.3 Other Disease Treatment
9.6 Historic and Forecast Market Size by Country
9.6.1 U.S.
9.6.2 Canada
9.6.3 Mexico
CHAPTER 10: EUROPE NSAIDS MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Aspirin
10.4.2 Ibuprofen
10.4.3 Naproxen
10.4.4 Nabumetone
10.4.5 Others
10.5 Historic and Forecasted Market Size By Application
10.5.1 Back Pain Treatment
10.5.2 Osteoarthritis Treatment
10.5.3 Other Disease Treatment
10.6 Historic and Forecast Market Size by Country
10.6.1 Germany
10.6.2 U.K.
10.6.3 France
10.6.4 Italy
10.6.5 Russia
10.6.6 Spain
10.6.7 Rest of Europe
CHAPTER 11: ASIA-PACIFIC NSAIDS MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Aspirin
11.4.2 Ibuprofen
11.4.3 Naproxen
11.4.4 Nabumetone
11.4.5 Others
11.5 Historic and Forecasted Market Size By Application
11.5.1 Back Pain Treatment
11.5.2 Osteoarthritis Treatment
11.5.3 Other Disease Treatment
11.6 Historic and Forecast Market Size by Country
11.6.1 China
11.6.2 India
11.6.3 Japan
11.6.4 Singapore
11.6.5 Australia
11.6.6 New Zealand
11.6.7 Rest of APAC
CHAPTER 12: MIDDLE EAST & AFRICA NSAIDS MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Aspirin
12.4.2 Ibuprofen
12.4.3 Naproxen
12.4.4 Nabumetone
12.4.5 Others
12.5 Historic and Forecasted Market Size By Application
12.5.1 Back Pain Treatment
12.5.2 Osteoarthritis Treatment
12.5.3 Other Disease Treatment
12.6 Historic and Forecast Market Size by Country
12.6.1 Turkey
12.6.2 Saudi Arabia
12.6.3 Iran
12.6.4 UAE
12.6.5 Africa
12.6.6 Rest of MEA
CHAPTER 13: SOUTH AMERICA NSAIDS MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Aspirin
13.4.2 Ibuprofen
13.4.3 Naproxen
13.4.4 Nabumetone
13.4.5 Others
13.5 Historic and Forecasted Market Size By Application
13.5.1 Back Pain Treatment
13.5.2 Osteoarthritis Treatment
13.5.3 Other Disease Treatment
13.6 Historic and Forecast Market Size by Country
13.6.1 Brazil
13.6.2 Argentina
13.6.3 Rest of SA
CHAPTER 14 INVESTMENT ANALYSIS
CHAPTER 15 ANALYST VIEWPOINT AND CONCLUSION
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
CHAPTER 2:EXECUTIVE SUMMARY
CHAPTER 3:GROWTH OPPORTUNITIES BY SEGMENT
3.1 By Type
3.2 By Application
CHAPTER 4: MARKET LANDSCAPE
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
CHAPTER 5: NSAIDS MARKET BY TYPE
5.1 Nsaids Market Overview Snapshot and Growth Engine
5.2 Nsaids Market Overview
5.3 Aspirin
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2016-2028F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Aspirin: Geographic Segmentation
5.4 Ibuprofen
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2016-2028F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Ibuprofen: Geographic Segmentation
5.5 Naproxen
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2016-2028F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Naproxen: Geographic Segmentation
5.6 Nabumetone
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2016-2028F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Nabumetone: Geographic Segmentation
5.7 Others
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size (2016-2028F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Others: Geographic Segmentation
CHAPTER 6: NSAIDS MARKET BY APPLICATION
6.1 Nsaids Market Overview Snapshot and Growth Engine
6.2 Nsaids Market Overview
6.3 Back Pain Treatment
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2016-2028F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Back Pain Treatment: Geographic Segmentation
6.4 Osteoarthritis Treatment
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2016-2028F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Osteoarthritis Treatment: Geographic Segmentation
6.5 Other Disease Treatment
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2016-2028F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Other Disease Treatment: Geographic Segmentation
CHAPTER 7: COMPANY PROFILES AND COMPETITIVE ANALYSIS
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Nsaids Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Nsaids Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Nsaids Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 SHANDONG XINHUA PHARMACEUTICAL CO LTD
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 ZHEJIANG JIUZHOU PHARMACEUTICAL
7.4 PFIZER
7.5 BOEHRINGER INGELHEIM
7.6 HISOAR
7.7 STRIDES SHASUN
7.8 AMGEN
7.9 JOHNSON AND JOHNSON
7.10 IOLCP
7.11 SANOFI
7.12 MERCK
7.13 GSK
7.14 ROCHE (GENENTECH)
7.15 SI GROUP
7.16 GRANULES BIOCAUSE
7.17 ZIBO XINHUA-PERRIGO PHARMACEUTICAL CO.
7.18 LTD.
7.19 BASF
7.20 NOVARTIS
7.21 ELI LILLY AND COMPANY
CHAPTER 8: GLOBAL NSAIDS MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Aspirin
8.2.2 Ibuprofen
8.2.3 Naproxen
8.2.4 Nabumetone
8.2.5 Others
8.3 Historic and Forecasted Market Size By Application
8.3.1 Back Pain Treatment
8.3.2 Osteoarthritis Treatment
8.3.3 Other Disease Treatment
CHAPTER 9: NORTH AMERICA NSAIDS MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Aspirin
9.4.2 Ibuprofen
9.4.3 Naproxen
9.4.4 Nabumetone
9.4.5 Others
9.5 Historic and Forecasted Market Size By Application
9.5.1 Back Pain Treatment
9.5.2 Osteoarthritis Treatment
9.5.3 Other Disease Treatment
9.6 Historic and Forecast Market Size by Country
9.6.1 U.S.
9.6.2 Canada
9.6.3 Mexico
CHAPTER 10: EUROPE NSAIDS MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Aspirin
10.4.2 Ibuprofen
10.4.3 Naproxen
10.4.4 Nabumetone
10.4.5 Others
10.5 Historic and Forecasted Market Size By Application
10.5.1 Back Pain Treatment
10.5.2 Osteoarthritis Treatment
10.5.3 Other Disease Treatment
10.6 Historic and Forecast Market Size by Country
10.6.1 Germany
10.6.2 U.K.
10.6.3 France
10.6.4 Italy
10.6.5 Russia
10.6.6 Spain
10.6.7 Rest of Europe
CHAPTER 11: ASIA-PACIFIC NSAIDS MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Aspirin
11.4.2 Ibuprofen
11.4.3 Naproxen
11.4.4 Nabumetone
11.4.5 Others
11.5 Historic and Forecasted Market Size By Application
11.5.1 Back Pain Treatment
11.5.2 Osteoarthritis Treatment
11.5.3 Other Disease Treatment
11.6 Historic and Forecast Market Size by Country
11.6.1 China
11.6.2 India
11.6.3 Japan
11.6.4 Singapore
11.6.5 Australia
11.6.6 New Zealand
11.6.7 Rest of APAC
CHAPTER 12: MIDDLE EAST & AFRICA NSAIDS MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Aspirin
12.4.2 Ibuprofen
12.4.3 Naproxen
12.4.4 Nabumetone
12.4.5 Others
12.5 Historic and Forecasted Market Size By Application
12.5.1 Back Pain Treatment
12.5.2 Osteoarthritis Treatment
12.5.3 Other Disease Treatment
12.6 Historic and Forecast Market Size by Country
12.6.1 Turkey
12.6.2 Saudi Arabia
12.6.3 Iran
12.6.4 UAE
12.6.5 Africa
12.6.6 Rest of MEA
CHAPTER 13: SOUTH AMERICA NSAIDS MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Aspirin
13.4.2 Ibuprofen
13.4.3 Naproxen
13.4.4 Nabumetone
13.4.5 Others
13.5 Historic and Forecasted Market Size By Application
13.5.1 Back Pain Treatment
13.5.2 Osteoarthritis Treatment
13.5.3 Other Disease Treatment
13.6 Historic and Forecast Market Size by Country
13.6.1 Brazil
13.6.2 Argentina
13.6.3 Rest of SA
CHAPTER 14 INVESTMENT ANALYSIS
CHAPTER 15 ANALYST VIEWPOINT AND CONCLUSION
LIST OF TABLES
TABLE 001. EXECUTIVE SUMMARY
TABLE 002. NSAIDS MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. NSAIDS MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. NSAIDS MARKET COMPETITIVE RIVALRY
TABLE 005. NSAIDS MARKET THREAT OF NEW ENTRANTS
TABLE 006. NSAIDS MARKET THREAT OF SUBSTITUTES
TABLE 007. NSAIDS MARKET BY TYPE
TABLE 008. ASPIRIN MARKET OVERVIEW (2016-2028)
TABLE 009. IBUPROFEN MARKET OVERVIEW (2016-2028)
TABLE 010. NAPROXEN MARKET OVERVIEW (2016-2028)
TABLE 011. NABUMETONE MARKET OVERVIEW (2016-2028)
TABLE 012. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 013. NSAIDS MARKET BY APPLICATION
TABLE 014. BACK PAIN TREATMENT MARKET OVERVIEW (2016-2028)
TABLE 015. OSTEOARTHRITIS TREATMENT MARKET OVERVIEW (2016-2028)
TABLE 016. OTHER DISEASE TREATMENT MARKET OVERVIEW (2016-2028)
TABLE 017. NORTH AMERICA NSAIDS MARKET, BY TYPE (2016-2028)
TABLE 018. NORTH AMERICA NSAIDS MARKET, BY APPLICATION (2016-2028)
TABLE 019. N NSAIDS MARKET, BY COUNTRY (2016-2028)
TABLE 020. EUROPE NSAIDS MARKET, BY TYPE (2016-2028)
TABLE 021. EUROPE NSAIDS MARKET, BY APPLICATION (2016-2028)
TABLE 022. NSAIDS MARKET, BY COUNTRY (2016-2028)
TABLE 023. ASIA PACIFIC NSAIDS MARKET, BY TYPE (2016-2028)
TABLE 024. ASIA PACIFIC NSAIDS MARKET, BY APPLICATION (2016-2028)
TABLE 025. NSAIDS MARKET, BY COUNTRY (2016-2028)
TABLE 026. MIDDLE EAST & AFRICA NSAIDS MARKET, BY TYPE (2016-2028)
TABLE 027. MIDDLE EAST & AFRICA NSAIDS MARKET, BY APPLICATION (2016-2028)
TABLE 028. NSAIDS MARKET, BY COUNTRY (2016-2028)
TABLE 029. SOUTH AMERICA NSAIDS MARKET, BY TYPE (2016-2028)
TABLE 030. SOUTH AMERICA NSAIDS MARKET, BY APPLICATION (2016-2028)
TABLE 031. NSAIDS MARKET, BY COUNTRY (2016-2028)
TABLE 032. SHANDONG XINHUA PHARMACEUTICAL CO LTD: SNAPSHOT
TABLE 033. SHANDONG XINHUA PHARMACEUTICAL CO LTD: BUSINESS PERFORMANCE
TABLE 034. SHANDONG XINHUA PHARMACEUTICAL CO LTD: PRODUCT PORTFOLIO
TABLE 035. SHANDONG XINHUA PHARMACEUTICAL CO LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 035. ZHEJIANG JIUZHOU PHARMACEUTICAL: SNAPSHOT
TABLE 036. ZHEJIANG JIUZHOU PHARMACEUTICAL: BUSINESS PERFORMANCE
TABLE 037. ZHEJIANG JIUZHOU PHARMACEUTICAL: PRODUCT PORTFOLIO
TABLE 038. ZHEJIANG JIUZHOU PHARMACEUTICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 038. PFIZER: SNAPSHOT
TABLE 039. PFIZER: BUSINESS PERFORMANCE
TABLE 040. PFIZER: PRODUCT PORTFOLIO
TABLE 041. PFIZER: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 041. BOEHRINGER INGELHEIM: SNAPSHOT
TABLE 042. BOEHRINGER INGELHEIM: BUSINESS PERFORMANCE
TABLE 043. BOEHRINGER INGELHEIM: PRODUCT PORTFOLIO
TABLE 044. BOEHRINGER INGELHEIM: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 044. HISOAR: SNAPSHOT
TABLE 045. HISOAR: BUSINESS PERFORMANCE
TABLE 046. HISOAR: PRODUCT PORTFOLIO
TABLE 047. HISOAR: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 047. STRIDES SHASUN: SNAPSHOT
TABLE 048. STRIDES SHASUN: BUSINESS PERFORMANCE
TABLE 049. STRIDES SHASUN: PRODUCT PORTFOLIO
TABLE 050. STRIDES SHASUN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 050. AMGEN: SNAPSHOT
TABLE 051. AMGEN: BUSINESS PERFORMANCE
TABLE 052. AMGEN: PRODUCT PORTFOLIO
TABLE 053. AMGEN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 053. JOHNSON AND JOHNSON: SNAPSHOT
TABLE 054. JOHNSON AND JOHNSON: BUSINESS PERFORMANCE
TABLE 055. JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
TABLE 056. JOHNSON AND JOHNSON: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 056. IOLCP: SNAPSHOT
TABLE 057. IOLCP: BUSINESS PERFORMANCE
TABLE 058. IOLCP: PRODUCT PORTFOLIO
TABLE 059. IOLCP: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 059. SANOFI: SNAPSHOT
TABLE 060. SANOFI: BUSINESS PERFORMANCE
TABLE 061. SANOFI: PRODUCT PORTFOLIO
TABLE 062. SANOFI: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 062. MERCK: SNAPSHOT
TABLE 063. MERCK: BUSINESS PERFORMANCE
TABLE 064. MERCK: PRODUCT PORTFOLIO
TABLE 065. MERCK: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 065. GSK: SNAPSHOT
TABLE 066. GSK: BUSINESS PERFORMANCE
TABLE 067. GSK: PRODUCT PORTFOLIO
TABLE 068. GSK: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 068. ROCHE (GENENTECH): SNAPSHOT
TABLE 069. ROCHE (GENENTECH): BUSINESS PERFORMANCE
TABLE 070. ROCHE (GENENTECH): PRODUCT PORTFOLIO
TABLE 071. ROCHE (GENENTECH): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 071. SI GROUP: SNAPSHOT
TABLE 072. SI GROUP: BUSINESS PERFORMANCE
TABLE 073. SI GROUP: PRODUCT PORTFOLIO
TABLE 074. SI GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 074. GRANULES BIOCAUSE: SNAPSHOT
TABLE 075. GRANULES BIOCAUSE: BUSINESS PERFORMANCE
TABLE 076. GRANULES BIOCAUSE: PRODUCT PORTFOLIO
TABLE 077. GRANULES BIOCAUSE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 077. ZIBO XINHUA-PERRIGO PHARMACEUTICAL CO.: SNAPSHOT
TABLE 078. ZIBO XINHUA-PERRIGO PHARMACEUTICAL CO.: BUSINESS PERFORMANCE
TABLE 079. ZIBO XINHUA-PERRIGO PHARMACEUTICAL CO.: PRODUCT PORTFOLIO
TABLE 080. ZIBO XINHUA-PERRIGO PHARMACEUTICAL CO.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 080. LTD.: SNAPSHOT
TABLE 081. LTD.: BUSINESS PERFORMANCE
TABLE 082. LTD.: PRODUCT PORTFOLIO
TABLE 083. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 083. BASF: SNAPSHOT
TABLE 084. BASF: BUSINESS PERFORMANCE
TABLE 085. BASF: PRODUCT PORTFOLIO
TABLE 086. BASF: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 086. NOVARTIS: SNAPSHOT
TABLE 087. NOVARTIS: BUSINESS PERFORMANCE
TABLE 088. NOVARTIS: PRODUCT PORTFOLIO
TABLE 089. NOVARTIS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 089. ELI LILLY AND COMPANY: SNAPSHOT
TABLE 090. ELI LILLY AND COMPANY: BUSINESS PERFORMANCE
TABLE 091. ELI LILLY AND COMPANY: PRODUCT PORTFOLIO
TABLE 092. ELI LILLY AND COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 001. EXECUTIVE SUMMARY
TABLE 002. NSAIDS MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. NSAIDS MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. NSAIDS MARKET COMPETITIVE RIVALRY
TABLE 005. NSAIDS MARKET THREAT OF NEW ENTRANTS
TABLE 006. NSAIDS MARKET THREAT OF SUBSTITUTES
TABLE 007. NSAIDS MARKET BY TYPE
TABLE 008. ASPIRIN MARKET OVERVIEW (2016-2028)
TABLE 009. IBUPROFEN MARKET OVERVIEW (2016-2028)
TABLE 010. NAPROXEN MARKET OVERVIEW (2016-2028)
TABLE 011. NABUMETONE MARKET OVERVIEW (2016-2028)
TABLE 012. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 013. NSAIDS MARKET BY APPLICATION
TABLE 014. BACK PAIN TREATMENT MARKET OVERVIEW (2016-2028)
TABLE 015. OSTEOARTHRITIS TREATMENT MARKET OVERVIEW (2016-2028)
TABLE 016. OTHER DISEASE TREATMENT MARKET OVERVIEW (2016-2028)
TABLE 017. NORTH AMERICA NSAIDS MARKET, BY TYPE (2016-2028)
TABLE 018. NORTH AMERICA NSAIDS MARKET, BY APPLICATION (2016-2028)
TABLE 019. N NSAIDS MARKET, BY COUNTRY (2016-2028)
TABLE 020. EUROPE NSAIDS MARKET, BY TYPE (2016-2028)
TABLE 021. EUROPE NSAIDS MARKET, BY APPLICATION (2016-2028)
TABLE 022. NSAIDS MARKET, BY COUNTRY (2016-2028)
TABLE 023. ASIA PACIFIC NSAIDS MARKET, BY TYPE (2016-2028)
TABLE 024. ASIA PACIFIC NSAIDS MARKET, BY APPLICATION (2016-2028)
TABLE 025. NSAIDS MARKET, BY COUNTRY (2016-2028)
TABLE 026. MIDDLE EAST & AFRICA NSAIDS MARKET, BY TYPE (2016-2028)
TABLE 027. MIDDLE EAST & AFRICA NSAIDS MARKET, BY APPLICATION (2016-2028)
TABLE 028. NSAIDS MARKET, BY COUNTRY (2016-2028)
TABLE 029. SOUTH AMERICA NSAIDS MARKET, BY TYPE (2016-2028)
TABLE 030. SOUTH AMERICA NSAIDS MARKET, BY APPLICATION (2016-2028)
TABLE 031. NSAIDS MARKET, BY COUNTRY (2016-2028)
TABLE 032. SHANDONG XINHUA PHARMACEUTICAL CO LTD: SNAPSHOT
TABLE 033. SHANDONG XINHUA PHARMACEUTICAL CO LTD: BUSINESS PERFORMANCE
TABLE 034. SHANDONG XINHUA PHARMACEUTICAL CO LTD: PRODUCT PORTFOLIO
TABLE 035. SHANDONG XINHUA PHARMACEUTICAL CO LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 035. ZHEJIANG JIUZHOU PHARMACEUTICAL: SNAPSHOT
TABLE 036. ZHEJIANG JIUZHOU PHARMACEUTICAL: BUSINESS PERFORMANCE
TABLE 037. ZHEJIANG JIUZHOU PHARMACEUTICAL: PRODUCT PORTFOLIO
TABLE 038. ZHEJIANG JIUZHOU PHARMACEUTICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 038. PFIZER: SNAPSHOT
TABLE 039. PFIZER: BUSINESS PERFORMANCE
TABLE 040. PFIZER: PRODUCT PORTFOLIO
TABLE 041. PFIZER: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 041. BOEHRINGER INGELHEIM: SNAPSHOT
TABLE 042. BOEHRINGER INGELHEIM: BUSINESS PERFORMANCE
TABLE 043. BOEHRINGER INGELHEIM: PRODUCT PORTFOLIO
TABLE 044. BOEHRINGER INGELHEIM: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 044. HISOAR: SNAPSHOT
TABLE 045. HISOAR: BUSINESS PERFORMANCE
TABLE 046. HISOAR: PRODUCT PORTFOLIO
TABLE 047. HISOAR: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 047. STRIDES SHASUN: SNAPSHOT
TABLE 048. STRIDES SHASUN: BUSINESS PERFORMANCE
TABLE 049. STRIDES SHASUN: PRODUCT PORTFOLIO
TABLE 050. STRIDES SHASUN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 050. AMGEN: SNAPSHOT
TABLE 051. AMGEN: BUSINESS PERFORMANCE
TABLE 052. AMGEN: PRODUCT PORTFOLIO
TABLE 053. AMGEN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 053. JOHNSON AND JOHNSON: SNAPSHOT
TABLE 054. JOHNSON AND JOHNSON: BUSINESS PERFORMANCE
TABLE 055. JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
TABLE 056. JOHNSON AND JOHNSON: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 056. IOLCP: SNAPSHOT
TABLE 057. IOLCP: BUSINESS PERFORMANCE
TABLE 058. IOLCP: PRODUCT PORTFOLIO
TABLE 059. IOLCP: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 059. SANOFI: SNAPSHOT
TABLE 060. SANOFI: BUSINESS PERFORMANCE
TABLE 061. SANOFI: PRODUCT PORTFOLIO
TABLE 062. SANOFI: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 062. MERCK: SNAPSHOT
TABLE 063. MERCK: BUSINESS PERFORMANCE
TABLE 064. MERCK: PRODUCT PORTFOLIO
TABLE 065. MERCK: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 065. GSK: SNAPSHOT
TABLE 066. GSK: BUSINESS PERFORMANCE
TABLE 067. GSK: PRODUCT PORTFOLIO
TABLE 068. GSK: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 068. ROCHE (GENENTECH): SNAPSHOT
TABLE 069. ROCHE (GENENTECH): BUSINESS PERFORMANCE
TABLE 070. ROCHE (GENENTECH): PRODUCT PORTFOLIO
TABLE 071. ROCHE (GENENTECH): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 071. SI GROUP: SNAPSHOT
TABLE 072. SI GROUP: BUSINESS PERFORMANCE
TABLE 073. SI GROUP: PRODUCT PORTFOLIO
TABLE 074. SI GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 074. GRANULES BIOCAUSE: SNAPSHOT
TABLE 075. GRANULES BIOCAUSE: BUSINESS PERFORMANCE
TABLE 076. GRANULES BIOCAUSE: PRODUCT PORTFOLIO
TABLE 077. GRANULES BIOCAUSE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 077. ZIBO XINHUA-PERRIGO PHARMACEUTICAL CO.: SNAPSHOT
TABLE 078. ZIBO XINHUA-PERRIGO PHARMACEUTICAL CO.: BUSINESS PERFORMANCE
TABLE 079. ZIBO XINHUA-PERRIGO PHARMACEUTICAL CO.: PRODUCT PORTFOLIO
TABLE 080. ZIBO XINHUA-PERRIGO PHARMACEUTICAL CO.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 080. LTD.: SNAPSHOT
TABLE 081. LTD.: BUSINESS PERFORMANCE
TABLE 082. LTD.: PRODUCT PORTFOLIO
TABLE 083. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 083. BASF: SNAPSHOT
TABLE 084. BASF: BUSINESS PERFORMANCE
TABLE 085. BASF: PRODUCT PORTFOLIO
TABLE 086. BASF: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 086. NOVARTIS: SNAPSHOT
TABLE 087. NOVARTIS: BUSINESS PERFORMANCE
TABLE 088. NOVARTIS: PRODUCT PORTFOLIO
TABLE 089. NOVARTIS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 089. ELI LILLY AND COMPANY: SNAPSHOT
TABLE 090. ELI LILLY AND COMPANY: BUSINESS PERFORMANCE
TABLE 091. ELI LILLY AND COMPANY: PRODUCT PORTFOLIO
TABLE 092. ELI LILLY AND COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. NSAIDS MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. NSAIDS MARKET OVERVIEW BY TYPE
FIGURE 012. ASPIRIN MARKET OVERVIEW (2016-2028)
FIGURE 013. IBUPROFEN MARKET OVERVIEW (2016-2028)
FIGURE 014. NAPROXEN MARKET OVERVIEW (2016-2028)
FIGURE 015. NABUMETONE MARKET OVERVIEW (2016-2028)
FIGURE 016. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 017. NSAIDS MARKET OVERVIEW BY APPLICATION
FIGURE 018. BACK PAIN TREATMENT MARKET OVERVIEW (2016-2028)
FIGURE 019. OSTEOARTHRITIS TREATMENT MARKET OVERVIEW (2016-2028)
FIGURE 020. OTHER DISEASE TREATMENT MARKET OVERVIEW (2016-2028)
FIGURE 021. NORTH AMERICA NSAIDS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 022. EUROPE NSAIDS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 023. ASIA PACIFIC NSAIDS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 024. MIDDLE EAST & AFRICA NSAIDS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 025. SOUTH AMERICA NSAIDS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. NSAIDS MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. NSAIDS MARKET OVERVIEW BY TYPE
FIGURE 012. ASPIRIN MARKET OVERVIEW (2016-2028)
FIGURE 013. IBUPROFEN MARKET OVERVIEW (2016-2028)
FIGURE 014. NAPROXEN MARKET OVERVIEW (2016-2028)
FIGURE 015. NABUMETONE MARKET OVERVIEW (2016-2028)
FIGURE 016. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 017. NSAIDS MARKET OVERVIEW BY APPLICATION
FIGURE 018. BACK PAIN TREATMENT MARKET OVERVIEW (2016-2028)
FIGURE 019. OSTEOARTHRITIS TREATMENT MARKET OVERVIEW (2016-2028)
FIGURE 020. OTHER DISEASE TREATMENT MARKET OVERVIEW (2016-2028)
FIGURE 021. NORTH AMERICA NSAIDS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 022. EUROPE NSAIDS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 023. ASIA PACIFIC NSAIDS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 024. MIDDLE EAST & AFRICA NSAIDS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 025. SOUTH AMERICA NSAIDS MARKET OVERVIEW BY COUNTRY (2016-2028)
